News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
728,913 Results
Type
Article (46966)
Company Profile (304)
Press Release (681633)
Multimedia
Podcasts (89)
Webinars (15)
Section
Business (209307)
Career Advice (2240)
Deals (36343)
Drug Delivery (111)
Drug Development (82751)
Employer Resources (177)
FDA (16451)
Job Trends (15294)
News (353531)
Policy (33338)
Tag
Academia (2594)
Accelerated approval (14)
Adcomms (27)
Allergies (101)
Alliances (51118)
ALS (123)
Alzheimer's disease (1525)
Antibody-drug conjugate (ADC) (174)
Approvals (16456)
Artificial intelligence (351)
Autoimmune disease (33)
Automation (22)
Bankruptcy (372)
Best Places to Work (11733)
BIOSECURE Act (20)
Biosimilars (130)
Biotechnology (222)
Bladder cancer (105)
Brain cancer (39)
Breast cancer (394)
Cancer (3178)
Cardiovascular disease (246)
Career advice (1862)
Career pathing (32)
CAR-T (209)
CDC (34)
Cell therapy (564)
Cervical cancer (25)
Clinical research (68377)
Collaboration (1167)
Company closure (4)
Compensation (784)
Complete response letters (36)
COVID-19 (2697)
CRISPR (68)
C-suite (417)
Cystic fibrosis (120)
Data (3354)
Decentralized trials (2)
Denatured (26)
Depression (78)
Diabetes (362)
Diagnostics (6529)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (155)
Drug pricing (142)
Drug shortages (28)
Duchenne muscular dystrophy (167)
Earnings (89381)
Editorial (46)
Employer branding (21)
Employer resources (154)
Events (117983)
Executive appointments (895)
FDA (18476)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1026)
Gene editing (148)
Generative AI (27)
Gene therapy (455)
GLP-1 (854)
Government (4611)
Grass and pollen (5)
Guidances (325)
Healthcare (18986)
HIV (42)
Huntington's disease (32)
IgA nephropathy (45)
Immunology and inflammation (179)
Immuno-oncology (16)
Indications (44)
Infectious disease (2885)
Inflammatory bowel disease (164)
Inflation Reduction Act (10)
Influenza (74)
Intellectual property (143)
Interviews (357)
IPO (16912)
IRA (50)
Job creations (3937)
Job search strategy (1592)
Kidney cancer (14)
Labor market (59)
Layoffs (538)
Leadership (24)
Legal (8143)
Liver cancer (82)
Longevity (12)
Lung cancer (434)
Lymphoma (233)
Machine learning (15)
Management (61)
Manufacturing (474)
MASH (104)
Medical device (13568)
Medtech (13580)
Mergers & acquisitions (20205)
Metabolic disorders (925)
Multiple sclerosis (104)
NASH (18)
Neurodegenerative disease (152)
Neuropsychiatric disorders (41)
Neuroscience (2307)
NextGen: Class of 2025 (6679)
Non-profit (4539)
Now hiring (53)
Obesity (459)
Opinion (271)
Ovarian cancer (106)
Pain (129)
Pancreatic cancer (137)
Parkinson's disease (198)
Partnered (25)
Patents (346)
Patient recruitment (215)
Peanut (51)
People (59585)
Pharmaceutical (69)
Pharmacy benefit managers (21)
Phase I (21396)
Phase II (30160)
Phase III (22321)
Pipeline (2267)
Policy (236)
Postmarket research (2588)
Preclinical (9115)
Press Release (72)
Prostate cancer (152)
Psychedelics (42)
Radiopharmaceuticals (258)
Rare diseases (536)
Real estate (6275)
Recruiting (68)
Regulatory (23423)
Reports (51)
Research institute (2383)
Resumes & cover letters (377)
Rett syndrome (11)
RNA editing (11)
RSV (55)
Schizophrenia (104)
Series A (174)
Series B (126)
Service/supplier (14)
Sickle cell disease (69)
Special edition (20)
Spinal muscular atrophy (150)
Sponsored (34)
Startups (3851)
State (2)
Stomach cancer (15)
Supply chain (83)
Tariffs (75)
The Weekly (61)
Vaccines (866)
Venture capital (62)
Weight loss (294)
Women's health (48)
Worklife (18)
Date
Last 7 days (449)
Last 30 days (2456)
Last 365 days (31714)
2025 (20228)
2024 (36003)
2023 (40707)
2022 (51900)
2021 (56368)
2020 (54690)
2019 (47153)
2018 (35599)
2017 (33138)
2016 (32595)
2015 (38465)
2014 (33845)
2013 (28963)
2012 (29450)
2011 (30119)
2010 (28199)
Location
Africa (807)
Alabama (65)
Alaska (7)
Arizona (254)
Arkansas (13)
Asia (40382)
Australia (6761)
California (8199)
Canada (2540)
China (746)
Colorado (345)
Connecticut (354)
Delaware (217)
Europe (88161)
Florida (1236)
Georgia (276)
Hawaii (2)
Idaho (60)
Illinois (693)
India (33)
Indiana (388)
Iowa (18)
Japan (247)
Kansas (117)
Kentucky (30)
Louisiana (16)
Maine (65)
Maryland (1112)
Massachusetts (6096)
Michigan (259)
Minnesota (500)
Mississippi (4)
Missouri (97)
Montana (31)
Nebraska (26)
Nevada (94)
New Hampshire (69)
New Jersey (2271)
New Mexico (29)
New York (2258)
North Carolina (1179)
North Dakota (9)
Northern California (3675)
Ohio (254)
Oklahoma (16)
Oregon (35)
Pennsylvania (1766)
Puerto Rico (17)
Rhode Island (39)
South America (1192)
South Carolina (39)
South Dakota (1)
Southern California (3105)
Tennessee (133)
Texas (1258)
United States (30236)
Utah (244)
Virginia (205)
Washington D.C. (73)
Washington State (690)
West Virginia (4)
Wisconsin (70)
728,913 Results for "pharmacyte biotech inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing
August 21, 2025
·
2 min read
Press Releases
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors
August 19, 2025
·
3 min read
Business
PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
PharmaCyte Biotech, Inc. today announced a $7 million investment in MyMD Pharmaceuticals, Inc.
May 21, 2024
·
4 min read
Mergers & acquisitions
Tang Capital’s Concentra on Buyout Binge With Plenty of Biotech Fodder
After a slow 2024, the biotech shell company Concentra Biosciences is back, offering to buy four biotechs in the past month and seven so far this year.
August 13, 2025
·
4 min read
·
Annalee Armstrong
Press Releases
BioDlink Strengthens Ecosystem Alliance to Empower Biotech Innovators Worldwide
- Alliance spans the full antibody drugs (mAbs/BsAbs), ADCs, fusion proteins, and other bioconjugates development and production lifecycle from bench to bedside and advances commercialization milestones - Alliance members include GlycanLink, Kexing Biopharm and industry chain partners, while innovative biotech clients include MediLink Therapeutics, Escugen and Smart Nuclide.
July 25, 2025
·
1 min read
Business
PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.
PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (“PharmaCyte” or the “Company”) announces it has made a $5 million investment in Femasys, Inc. (Nasdaq:FEMY) (“Femasys”), a biomedical company focused on meeting significant unmet needs for women worldwide.
November 15, 2023
·
4 min read
Press Releases
Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
August 18, 2025
·
2 min read
Earnings
Q2 2025: Biotechs To Watch For This Earnings Season
Second-quarter earnings come amid many high-level challenges for the biopharma industry. How will these five closely watched biotechs fare?
July 24, 2025
·
10 min read
·
Tristan Manalac
Business
Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech
Femasys Inc. today announced a strategic upfront investment of $6.85 million by public biotech company, PharmaCyte Biotech, Inc. (Nasdaq: PMCB) and other healthcare investors.
November 15, 2023
·
6 min read
Press Releases
Moleculin Biotech, Inc. Unveils Promising Preclinical Data of Annamycin in Liver Cancer Treatment
August 7, 2025
·
7 min read
1 of 72,892
Next
